Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone

被引:14
|
作者
Egorova, Polina A. [1 ]
Gavrilova, Aleksandra V. [1 ]
Bezprozvanny, Ilya B. [1 ,2 ]
机构
[1] Peter Great St Petersburg Polytech Univ, Lab Mol Neurodegenerat, St Petersburg, Russia
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA
基金
俄罗斯科学基金会;
关键词
ataxia; cerebellum; Huntington's disease; transgenic mice; chlorzoxazone; BETA-III SPECTRIN; PURKINJE-CELLS; POTASSIUM CHANNELS; CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEAT; DOUBLE-BLIND; DYSFUNCTION; MOTOR; GENE; MODULATOR;
D O I
10.3389/fnins.2020.00279
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein, Striatum atrophy in HD leads to a progressive disturbance of psychiatric, motor, and cognitive function. Recent studies of HD patients revealed that the degeneration of cerebellum is also observed independently from the striatal atrophy during early HD stage and may contribute to the motor impairment and ataxia observed in HD. Cerebellar Purkinje cells (PCs) are responsible for the proper cerebellar pathways functioning and motor control. Recent studies on mouse models of HD have shown that the abnormality of the biochemical functions of PCs are observed in HD, suggesting the contribution of PC dysfunction and death to the impaired movement coordination observed in HD. To investigate ataxic symptoms in HD we performed a series of experiments with the yeast artificial chromosome transgenic mouse model of HD (YAC128). Using extracellular single-unit recording method we found that the portion of the cerebellar PCs with bursting and irregular patterns of spontaneous activity drastically rises in aged YAC128 HD mice when compared with wild type littermates. Previous studies demonstrated that SK channels are responsible for the cerebellar PC pacemaker activity and that positive modulation of SK channel activity exerted beneficial effects in different ataxic mouse models. Here we studied effects of the SK channels modulator chlorzoxazone (CHZ) on the motor behavior of YAC128 HD mice and also on the electrophysiological activity and neuroanatomy of the cerebellar PCs from these mice. We determined that the long-term intraperitoneal injections of CHZ alleviated the progressive impairment in the firing pattern of YAC128 PCs. We also demonstrated that treatment with CHZ rescued age-dependent motor incoordination and improved the cerebellar morphology in YAC128 mice. We propose that abnormal changes in the PC firing patterns might be a one of the possible causes of ataxic symptoms in HD and in other polyglutamine disorders and that the pharmacological activation of SK channels may serve as a potential way to improve the activity of cerebellar PCs and relieve the ataxic phenotype in HD patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease
    Renoir, Thibault
    Argyropoulos, Andrew
    Chevarin, Caroline
    Lanfumey, Laurence
    Hannan, Anthony J.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 127 : 15 - 20
  • [22] Neuroinflammation in the YAC128 transgenic mouse model of Huntington's disease
    Connolly, C.
    Thiele, J.
    Beck, J.
    Lefroy, C.
    Hill, A.
    Leavitt, B. R.
    MOVEMENT DISORDERS, 2012, 27 : S58 - S58
  • [23] Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease
    Kiriazis, Helen
    Jennings, Nicole L.
    Davern, Pamela
    Lambert, Gavin
    Su, Yidan
    Pang, Terence
    Du, Xin
    La Greca, Luisa
    Head, Geoffrey A.
    Hannan, Anthony J.
    Du, Xiao-Jun
    JOURNAL OF PHYSIOLOGY-LONDON, 2012, 590 (22): : 5845 - 5860
  • [24] Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
    Bogdanov, MB
    Andreassen, OA
    Dedeoglu, A
    Ferrante, RJ
    Beal, MF
    JOURNAL OF NEUROCHEMISTRY, 2001, 79 (06) : 1246 - 1249
  • [25] Transgenic mouse models for Huntington's disease.
    Reddy, PH
    Williams, M
    Miller, G
    Glass, M
    Paylor, R
    Garrett, L
    Herkenham, M
    Crawley, J
    Tagle, DA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A52 - A52
  • [26] Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
    S Zhu
    Y Zhang
    G Bai
    H Li
    Cell Death & Disease, 2011, 2 : e115 - e115
  • [27] Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
    Zhu, S.
    Zhang, Y.
    Bai, G.
    Li, H.
    CELL DEATH & DISEASE, 2011, 2 : e115 - e115
  • [28] A Transgenic Minipig Model of Huntington's Disease
    Baxa, Monika
    Hruska-Plochan, Marian
    Juhas, Stefan
    Vodicka, Petr
    Pavlok, Antonin
    Juhasova, Jana
    Miyanohara, Atsushi
    Nejime, Tetsuya
    Klima, Jiri
    Macakova, Monika
    Marsala, Silvia
    Weiss, Andreas
    Kubickova, Svatava
    Musilova, Petra
    Vrtel, Radek
    Sontag, Emily M.
    Thompson, Leslie M.
    Schier, Jan
    Hansikova, Hana
    Howland, David S.
    Cattaneo, Elena
    DiFiglia, Marian
    Marsala, Martin
    Motlik, Jan
    JOURNAL OF HUNTINGTONS DISEASE, 2013, 2 (01) : 47 - 68
  • [29] Transgenic rat model of Huntington's disease
    von Hörsten, S
    Schmitt, I
    Nguyen, HP
    Holzmann, C
    Schmidt, T
    Walther, T
    Bader, M
    Pabst, R
    Kobbe, P
    Krotova, J
    Stiller, D
    Kask, A
    Vaarmann, A
    Rathke-Hartlieb, S
    Schulz, JB
    Grasshoff, U
    Bauer, I
    Vieira-Saecker, AMM
    Paul, M
    Jones, L
    Lindenberg, KS
    Landwehrmeyer, B
    Bauer, A
    Li, XJ
    Riess, O
    HUMAN MOLECULAR GENETICS, 2003, 12 (06) : 617 - 624
  • [30] An ovine transgenic Huntington's disease model
    Jacobsen, Jessie C.
    Bawden, C. Simon
    Rudiger, Skye R.
    McLaughlan, Clive J.
    Reid, Suzanne J.
    Waldvogel, Henry J.
    MacDonald, Marcy E.
    Gusella, James F.
    Walker, Simon K.
    Kelly, Jennifer M.
    Webb, Graham C.
    Faull, Richard L. M.
    Rees, Mark I.
    Snell, Russell G.
    HUMAN MOLECULAR GENETICS, 2010, 19 (10) : 1873 - 1882